In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Wockhardt Ltd.

www.wockhardtin.com

Latest From Wockhardt Ltd.

Facing Regulatory Heat, Indian Pharma Turns To Quality Solutions

Against a backdrop of US FDA warnings and global regulatory convergence, the Indian pharma industry is looking to build in quality from project inception and foster an unbiased approach to quality across global markets, a conference in Mumbai hears.

 

India Quality

Torrent Makes A ‘Cautious’ Comeback With Losartan In US

Torrent restarts sale of losartan in the US, exercising caution to ensure the API sourced is “impurity free.” Timely resolution of compliance deviations at the firm’s Indian sites is also critical for growth momentum in the US.

Compliance Sales & Earnings

Torrent Makes ‘Cautious’ Comeback With Losartan In US

Torrent restarts sale of losartan in the US, exercising caution to ensure the API sourced is “impurity free.” Timely resolution of compliance deviations at the firm’s Indian sites is also critical for growth momentum in the US.

Compliance Sales & Earnings

Buyout Firms Eye Wockhardt’s Domestic Formulations Unit

Private-equity firms are reportedly in talks to acquire a controlling stake in the domestic formulations business of India’s Wockhardt, which is seeking funds to pay down significant debts.

Deals Strategy
See All

Company Information

Advertisement
Advertisement
UsernamePublicRestriction

Register